L

Lytix Biopharma AS
OSE:LYTIX

Watchlist Manager
Lytix Biopharma AS
OSE:LYTIX
Watchlist
Price: 6.88 NOK 0.88% Market Closed
Market Cap: 341.3m NOK
Have any thoughts about
Lytix Biopharma AS?
Write Note

Lytix Biopharma AS
Total Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Lytix Biopharma AS
Total Equity Peer Comparison

Comparables:
HBC
B
BGBIO
AZT
N
NYKD
T
TRMED

Competitive Total Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Equity CAGR 3Y CAGR 5Y CAGR 10Y
L
Lytix Biopharma AS
OSE:LYTIX
Total Equity
kr51.3m
CAGR 3-Years
37%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Hofseth Biocare ASA
OSE:HBC
Total Equity
kr138.2m
CAGR 3-Years
-14%
CAGR 5-Years
23%
CAGR 10-Years
2%
B
Bergenbio ASA
OSE:BGBIO
Total Equity
kr175.3m
CAGR 3-Years
-30%
CAGR 5-Years
-11%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Total Equity
kr317.5m
CAGR 3-Years
13%
CAGR 5-Years
47%
CAGR 10-Years
11%
N
Nykode Therapeutics ASA
OSE:NYKD
Total Equity
$152.1m
CAGR 3-Years
-3%
CAGR 5-Years
32%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Total Equity
kr260m
CAGR 3-Years
-11%
CAGR 5-Years
-8%
CAGR 10-Years
17%

See Also

What is Lytix Biopharma AS's Total Equity?
Total Equity
51.3m NOK

Based on the financial report for Dec 31, 2023, Lytix Biopharma AS's Total Equity amounts to 51.3m NOK.

What is Lytix Biopharma AS's Total Equity growth rate?
Total Equity CAGR 5Y
5%

Over the last year, the Total Equity growth was -62%. The average annual Total Equity growth rates for Lytix Biopharma AS have been 37% over the past three years , 5% over the past five years .

Back to Top